E.e.s Granule, For Suspension
NDC Package 80005-152-18
Package Information
E.e.s (erythromycin ethylsuccinate) granules is erythromycin is used to treat a wide variety of bacterial infections. This formulation utilizes a granule, for suspension delivery system. Marketed by Carnegie Pharmaceuticals Llc, this product is identified by NDC 80005-152 and is authorized under FDA application NDA050207.
Identification & Billing
- RxCUI: 686400 - erythromycin ethylsuccinate 200 MG in 5 mL Oral Suspension
- RxCUI: 686400 - erythromycin ethylsuccinate 40 MG/ML Oral Suspension
- RxCUI: 686400 - EES 40 MG/ML Oral Suspension
- RxCUI: 686400 - erythromycin ethylsuccinate 200 MG per 5 ML Oral Suspension
- RxCUI: 686405 - erythromycin ethylsuccinate 400 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 80005 - Carnegie Pharmaceuticals Llc
- 80005-152 - E.e.s
- 80005-152-18 - 100 mL in 1 BOTTLE
- 80005-152 - E.e.s
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 80005-152-18 identifies a specific commercial package of 100 ml in 1 bottle of E.e.s, a human prescription drug labeled by Carnegie Pharmaceuticals Llc. This granule, for suspension is formulated for oral use and contains erythromycin ethylsuccinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Carnegie Pharmaceuticals Llc on January 15, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Erythromycin is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Carnegie Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 80005015218. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.